Advertising injectables without an ASA ruling

In 2024 the MHRA issued 47 enforcement notices to aesthetic businesses for illegally advertising prescription-only medicines (MHRA, 2024). Over the same period the ASA wrote to more than 60 training academies asking them to cascade the advertising rules down to the practitioners they teach (CAP/ASA, 2024). Very few of the people on the receiving end of those letters thought they were doing anything wrong. They put “Botox £150” on an Instagram grid because every other clinic in town seemed to, and assumed anything that common must be legal.

It is not. The rules are strict, mostly logical once you see the principle behind them, and cheap to follow. A published ASA ruling with your clinic’s name in it is not cheap; it sits on a public database forever and insurers and licensing bodies can read. This guide covers what the rules actually say, how enforcement happens in practice, what two upheld rulings teach, and wording patterns that survive scrutiny. If you are still mapping the career itself, start with how to become an aesthetic practitioner and come back.

The rule that matters

Botulinum toxin is a prescription-only medicine (POM), and rule 12.12 of the CAP Code prohibits advertising POMs to the public. Not “advertising them carelessly”. Advertising them at all. The prohibition covers brand names (Botox, Bocouture, Azzalure and the rest), “Botox” used as a generic word, and, per CAP’s published guidance, hashtags such as #botox attached to an otherwise innocent post. A hashtag is advertising content, not decoration.

The test is not whether you typed a trademark. It is whether a member of the public would understand your material as promoting a prescription-only treatment. “Anti-wrinkle injections £99” fails that test just as thoroughly as “Botox £99”, which the ASA has confirmed in an upheld ruling (more below).

Dermal fillers are different. Fillers are not POMs and may be advertised, but the general code applies in full: no misleading claims, no trivialising a medical procedure, socially responsible presentation, nothing aimed at under-18s. Separately, administering toxin or filler to under-18s for cosmetic purposes has been a criminal offence in England since 2021 (Botulinum Toxin and Cosmetic Fillers (Children) Act 2021), so youthful targeting is a problem on two fronts.

How enforcement happens

Nobody needs to raid your clinic. The chain usually runs like this.

• The ASA monitors ads proactively, including social media, and acts on complaints from the public. A decent share of complaints come from competitors, which is worth knowing before you assume nobody local is reading your captions.
• Where a POM is being advertised, the MHRA can act directly. It issued 47 enforcement notices to aesthetic businesses in 2024 over illegal POM advertising (MHRA, 2024).
• The ASA has contacted more than 60 training academies to push the rules through the sector (CAP/ASA, 2024), which makes “nobody ever told me” a thinner defence every year.
• Escalation for non-compliance includes a published named ruling, takedown demands, paid-search sanctions and referral to Trading Standards or the MHRA.

Regulation of the wider sector is tightening too; the direction of travel is covered in our licensing tracker. Advertising is simply the part that can already bite today.

Two rulings worth reading

Dr Bunny Aesthetics, 2024

The clinic promoted “anti-wrinkle” and “anti-ageing toxin” treatment. The ASA upheld the complaint: the wording still promoted a prescription-only medicine, because readers understood exactly what was on offer (ASA ruling, 2024). The lesson is that euphemism does not launder a POM ad. If your audience knows you mean botulinum toxin, you have advertised botulinum toxin, whatever synonym you reached for. Half the sector still believes “anti-wrinkle injections” is the safe phrase. It is not.

LIFT Aesthetics, 2023

This ruling combined a POM promotion with celebrity association (ASA ruling, 2023). Two lessons. First, borrowed fame compounds a breach rather than diluting it, since the code restricts using celebrities to promote medicines. Second, reposting glamour content that features a named treatment is itself advertising. “I only shared it” is not a category the CAP Code recognises.

What you may advertise

The compliant space is bigger than the horror stories suggest.

• A consultation. “Consultations for frown lines and facial ageing” is advertisable, because you are promoting an assessment, not a medicine.
• Your clinic and yourself: registration, qualifications, experience, premises, your consultation process, your aftercare.
• Dermal filler treatments, described and priced, provided every claim is accurate and the presentation is responsible.
• Skincare and other non-POM treatments, under the ordinary rules.

Whatever you advertise, placement and targeting must exclude under-18s, and content must not be designed to appeal to them.

Wording that survives

These are generic patterns we have written for illustration, not magic formulas. Context can still sink careful copy, and careless context can sink compliant copy.

Sanctionable	Compliant alternative	Why
“Botox £150”	“Consultations for frown lines, from £150”	A POM name plus a price is an advert for the POM. A consultation is a service you may promote.
“Anti-wrinkle injections, 3 areas £199”	“Concerned about forehead or frown lines? Book a consultation.”	The euphemism still identifies the POM (the Dr Bunny Aesthetics logic, ASA 2024).
#botox #antiwrinkleinjections on a public post	#aestheticclinic #skinhealth	CAP guidance treats hashtags as advertising content.
“Baby Botox now available”	“New consultation appointments available this month”	Brand name plus treatment promotion, twice over.
“Lip filler, guaranteed natural results”	“Lip filler from £180. Results vary; consultation comes first.”	Fillers may be advertised, but guarantees are misleading claims.
“Flash sale, 20% off filler this weekend only”	“Filler prices are published on our price list.”	Urgency mechanics on injectable procedures risk breaching social-responsibility rules.

Build around the consultation

The compliant website structure follows directly from the rule, and it happens to be good medicine as well as good law. Public-facing pages promote the consultation; the toxin conversation happens inside it.

In practice that means your homepage and service pages describe concerns (frown lines, forehead lines, volume loss) and offer an assessment. Filler pages can be genuine treatment pages with prices. A price list can carry the consultation fee and “from” prices for non-POM treatments. Toxin is then discussed, and prescribed or declined, at a face-to-face consultation with the prescriber, which is exactly what prescribing regulation demands anyway (see our insurance and prescribing guide). Factual, non-promotional treatment information can be given to a patient who has already sought it; what you cannot do is push the medicine at people who have not.

Social media specifics

• Hashtags count. #botox, #botoxlips, #antiwrinkle: all advertising a POM, per CAP guidance.
• Before-and-after photographs of toxin results promote the POM and belong off your public feeds. Filler before-and-afters are permitted if they are your own work, un-retouched, and captioned honestly.
• Influencer and affiliate content is your advertising. A gifted post with your discount code must follow the same POM rules and be labelled as an ad. The LIFT ruling (ASA, 2023) shows how celebrity content compounds a breach.
• Paid boosts must be targeted 18-plus, and organic content should not lean on youth-coded trends or imagery.
• Patient testimonials in your marketing must not reference POM treatments.

The pre-publish checklist

1. No POM brand names, no “Botox” as a generic, no euphemisms that identify toxin, in copy, captions or hashtags.
2. Where toxin is concerned, the offer on the page is a consultation, not a treatment.
3. Filler claims accurate, no guarantees, result photos your own and unfiltered.
4. No countdowns, flash sales or urgency mechanics on any injectable.
5. Targeting set to 18-plus and the content itself holds no appeal to minors.
6. Influencer and affiliate posts checked against the same rules and disclosed as ads.
7. Prices complete and honest, with no surprises held back for the consultation room.
8. Testimonials screened for POM references.
9. Someone other than the author has read the post against the CAP Code before it goes out.

Why a trainer cares

We teach this material because we watch what happens without it. A career that starts with a published ASA ruling starts slower, and the fix costs nothing but discipline. Delegates on our foundation botox and dermal filler course leave knowing the prescribing and advertising rules alongside the injection technique, alumni can bring draft copy questions to our monthly case-review calls, and anything we have not covered here is probably answered on our questions page. If it is not, ask us; the honest answer is house style.

Rulings and enforcement actions move faster than guides. The ASA enforcement tracker keeps the running score, reviewed quarterly.

This guide is editorial information, not legal advice. Rules and figures checked 11 July 2026.